美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CST Brands Inc

48.53

0.0000

成交量：- -

成交額：- -

市值：36.85億

市盈率：11.45

高：48.53

開：48.53

低：48.53

收：48.53

52周最高：48.56

52周最低：40.85

股本：7,592.50萬

流通股本：7,510.00萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):4.24

淨資產收益率：--

總資產收益率：--

市淨率：2.08

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

聯盟成員-榮昌生物與日本參天製藥就眼科創新藥RC28-E達成大中華及亞洲地區獨家授權合作

生物医药创投服...

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CST"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CST\",,,,,undefined,":{"symbol":"CST","market":"US","secType":"STK","nameCN":"CST Brands Inc","latestPrice":48.53,"timestamp":1575666000000,"preClose":48.53,"halted":4,"volume":0,"delay":0,"floatShares":75100000,"shares":75925000,"eps":4.24,"marketStatus":"退市","change":0,"latestTime":"12-06 16:00:00 EST","open":48.53,"high":48.53,"low":48.53,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.24,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":48.53,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CST\",,,,,undefined,":{"symbol":"CST","floatShares":75100000,"roa":"--","roe":"--","lyrEps":0,"shares":75925000,"dividePrice":0,"high":48.53,"amplitude":0,"preClose":48.53,"low":48.53,"week52Low":40.85,"pbRate":"2.08","week52High":48.555,"institutionHeld":0,"latestPrice":48.53,"eps":4.24,"divideRate":0,"volume":0,"delay":0,"ttmEps":4.24,"open":48.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-08","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1494216000000,"reportTimeType":"post","actualEps":0.15},{"market":"US","date":"2017-02-27","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.35,"name":null,"time":"盤後","type":"earning","dateTimestamp":1488171600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-11-07","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.63,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478494800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-08-05","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.41,"name":null,"time":"盤前","type":"earning","dateTimestamp":1470369600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-06","symbol":"CST","fiscalQuarterEnding":null,"expectedEps":0.27,"name":null,"time":"盤前","type":"earning","dateTimestamp":1462507200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CST\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CST\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561448137","title":"聯盟成員-榮昌生物與日本參天製藥就眼科創新藥RC28-E達成大中華及亞洲地區獨家授權合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2561448137","media":"生物医药创投服...","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561448137?lang=zh_tw&edition=fundamental","pubTime":"2025-08-20 17:28","pubTimestamp":1755682108,"startTime":"0","endTime":"0","summary":"北京时间2025年8月19日，联盟成员-荣昌生物制药（烟台）股份有限公司宣布，与日本参天制药株式会社全资子公司参天制药（中国）有限公司达成协议，将公司具有自主知识产权的RC28-E注射液有偿许可给参天中国。左：荣昌生物CEO房健民博士右：参天公司总裁、首席执行官伊藤毅RC28-E注射液是由荣昌生物自主研发的针对眼部新生血管性疾病的VEGF/FGF双靶标融合蛋白药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820173043a493b4b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820173043a493b4b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CST"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CST\",params:#limit:6,delay:false,,,undefined,":[]}}